Related Experiment Video

Updated: May 16, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Cardiac resynchronization therapy for prevention of heart failure events in elderly patients with left ventricular

Olena Dotsenko1, Alon Barsheshet, David T Huang

  • 1Cardiology Division, University of Rochester Medical Center, Rochester, NY 14642, USA.

Expert Review of Cardiovascular Therapy
|November 30, 2012
PubMed

Insights

Cardiac resynchronization therapy (CRT) benefits elderly patients with heart failure (HF) and left ventricular (LV) systolic dysfunction. Evidence suggests CRT may prevent disease progression and offers significant clinical advantages in older populations.

Area of Science:

  • Cardiology
  • Geriatrics

Background:

  • Heart failure (HF) from left ventricular (LV) systolic dysfunction is a growing global health concern, particularly in aging populations.
  • Elderly individuals face increased risks due to age-related cardiac changes and comorbidities, reducing cardiovascular reserve.
  • Cardiac resynchronization therapy (CRT) is established for advanced HF, reducing hospitalizations and mortality.

Purpose of the Study:

  • To evaluate the efficacy and benefits of CRT in elderly patients with LV systolic dysfunction.
  • To explore the potential of CRT in preventing or delaying HF progression in older adults.
  • To assess if CRT offers comparable or superior benefits in the elderly compared to younger patients.

Main Methods:

  • Review of recent studies and retrospective subgroup analyses focusing on CRT in HF patients.
  • Analysis of data concerning CRT's impact on HF risk, mortality, and disease progression.
  • Comparison of CRT outcomes in elderly versus younger patient cohorts.

Main Results:

  • Recent studies indicate CRT reduces HF risk and mortality even in asymptomatic or mildly symptomatic patients with LV dysfunction and widened QRS.
  • Accumulating data suggest CRT provides similar or greater clinical benefits in elderly patients compared to younger individuals.
  • CRT may prevent or delay the progression of HF in qualified patients, including the elderly.

Conclusions:

  • CRT is a valuable therapeutic option for elderly patients with LV systolic dysfunction and HF.
  • Further research is essential to confirm the widespread clinical benefits of preventive CRT in the growing elderly population.
  • CRT demonstrates potential to improve outcomes and delay disease progression in older adults with HF.

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...